SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-16-111303
Filing Date
2016-03-31
Accepted
2016-03-31 20:19:25
Documents
2
Period of Report
2016-03-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2927
2 POA DOCUMENT poa.txt EX-24.3_645512 1264
  Complete submission text file 0001209191-16-111303.txt   5704
Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306
Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-272-6138
Eiger BioPharmaceuticals, Inc. (Issuer) CIK: 0001305253 (see all company filings)

IRS No.: 330971591 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O INTERWEST PARTNERS 2710 SAND HILL ROAD, SECOND FLOOR MENLO PARK CA 94025
Business Address
Kjellson Nina S (Reporting) CIK: 0001381980 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36183 | Film No.: 161544720